ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Irlen Institute Announces Eleventh Annual International Awareness Week for Visual Processing Disorder

Long Beach, California - October 27, 2025 - PRESSADVANTAGE -

The Irlen Institute marks the eleventh annual International Irlen Syndrome Awareness Week that took place from October 13-17, 2025, drawing attention to a visual processing disorder that affects approximately 15 percent of the general population. The global awareness campaign educates the public about Irlen Syndrome, a condition that impacts the brain's ability to process visual information and can cause significant challenges in daily functioning.

Irlen Syndrome manifests through various symptoms, including light sensitivity, headaches or migraines, reading difficulties, eye strain, and distorted perception of printed text or environmental surroundings. Despite affecting millions worldwide, the condition remains undetected by standard educational and medical testing protocols, leading to widespread misdiagnosis and unnecessary suffering.

The statistics surrounding Irlen Syndrome reveal its extensive impact across different populations. Research indicates that 50 percent of individuals with reading and learning difficulties, 30 percent of people diagnosed with ADHD and autism, and approximately 15 percent of the general population struggle with this condition. The syndrome has also been linked to brain injury, chronic headaches, and persistent migraines.

"Irlen Syndrome is more common than heart disease or asthma, yet most sufferers remain unaware of the true source of their problems," said Sandra Tosta, Ph.D., spokesperson for The Irlen Institute. "Through International Irlen Syndrome Awareness Week, we aim to move away from costly misdiagnoses and help individuals access readily available solutions that can dramatically improve their quality of life."

The awareness week featured multiple educational initiatives designed to reach diverse audiences. Beginning with the release of “When Light Overwhelms the Brain,” a new video explaining the impact of light on brain function, other awareness activities included webinars, lectures, and complimentary mini-screenings for Irlen Syndrome. Testimonials shared personal experiences with the condition, and complimentary consultations and self-tests were available online through the Irlen Institute's website.

The consequences of undiagnosed Irlen Syndrome extend beyond physical symptoms. Untreated individuals may experience academic and workplace challenges, ongoing physical and emotional distress, and in some cases, increased likelihood of involvement with the criminal justice system. Early identification and treatment through specialized spectral filters can significantly improve visual processing and overall quality of life.

The Irlen Institute, founded by Helen Irlen, pioneered the use of color-based technology to address visual processing difficulties. The organization's research, initially conducted under a federal grant, demonstrated that personalized spectral filters could significantly improve visual processing. This innovative approach has since helped millions of individuals worldwide through specialized lenses and overlays.

The Irlen Institute maintains a global network of more than 170 affiliated clinics and thousands of certified screeners across 46 countries. The organization collaborates with nonprofits and institutions, including the Irlen Syndrome Foundation and The Semper Fi Fund, to facilitate identification, intervention, and care for individuals with Irlen Syndrome. The Institute continues to conduct research and develop solutions for those affected by light-based visual processing difficulties.

###

For more information about The Irlen Institute, contact the company here:

The Irlen Institute
Sandra Tosta
562-496-2550
sandy@irlen.com
5380 E. Village Road
Long Beach, CA 90808

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+3.99 (1.63%)
AAPL  269.43
+0.96 (0.36%)
AMD  243.98
+10.44 (4.47%)
BAC  53.42
+0.22 (0.41%)
GOOG  290.59
+10.89 (3.89%)
META  631.76
+10.05 (1.62%)
MSFT  506.00
+9.18 (1.85%)
NVDA  199.05
+10.90 (5.79%)
ORCL  240.83
+1.57 (0.66%)
TSLA  445.23
+15.71 (3.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.